These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3674502)

  • 21. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
    Schuh FT
    Klin Anasthesiol Intensivther; 1980; 22():158-74. PubMed ID: 6108384
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of succinylcholine and rocuronium on the laryngeal neuromuscular junction.
    Weinbren J
    Br J Anaesth; 2000 Dec; 85(6):939-40. PubMed ID: 11732541
    [No Abstract]   [Full Text] [Related]  

  • 23. Muscle relaxants and reversal agents.
    Van Sickel AD; Spadaccia K
    Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cholinesterase activity and tachyphylaxis during prolonged succinylcholine infusion.
    Delisle S; Lebrun M; Bevan DR
    Anesth Analg; 1982 Nov; 61(11):941-4. PubMed ID: 7137612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of succinylcholine block by metoclopramide.
    Kao YJ; Turner DR
    Anesthesiology; 1989 Jun; 70(6):905-8. PubMed ID: 2658689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural components of beta-eudesmol essential for its potentiating effect on succinylcholine-induced neuromuscular blockade in mice.
    Kimura M; Tanaka K; Takamura Y; Nojima H; Kimura I; Yano S; Tanaka M
    Biol Pharm Bull; 1994 Sep; 17(9):1232-40. PubMed ID: 7841945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cholinesterase and the duration of succinylcholine-induced apnea.
    LOTSHAW RL
    J Oral Surg Anesth Hosp Dent Serv; 1960 Mar; 18():116-21. PubMed ID: 14418385
    [No Abstract]   [Full Text] [Related]  

  • 28. [Practical importance of the determination of plasma cholinesterase and the study of its atypical effects with regard to succinylcholine].
    DOENICKE A; HOLLE F; FREY HH
    Cah Anesthesiol; 1962 Jun; 9():673-92. PubMed ID: 13886906
    [No Abstract]   [Full Text] [Related]  

  • 29. [Degradation of the curare-like action of succinylcholine by a cholinesterase reactivator].
    Betti V
    Minerva Anestesiol; 1967 Feb; 33(2):159-61. PubMed ID: 5602387
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacodynamic examples on the effect enhancement or alteration of action through molecular dimerization].
    Kraupp VO
    Wien Med Wochenschr; 1975 Jan; 125(1-3):23-9. PubMed ID: 165643
    [No Abstract]   [Full Text] [Related]  

  • 31. Variation in the cholinesterase-inhibiting effect of succinylcholine.
    STOVNER J
    Scand J Clin Lab Invest; 1955; 7(3):197-200. PubMed ID: 13298593
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuromuscular blockade of atracurium versus succinylcholine in a patient with complete absence of plasma cholinesterase activity.
    Baraka A
    Anesthesiology; 1987 Jan; 66(1):80-1. PubMed ID: 3026208
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuromuscular blocking agents: a review.
    Comfort M
    AANA J; 1981 Apr; 49(2):159-65. PubMed ID: 6261512
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholinesterase. Its significance in anaesthetic practice.
    Davis L; Britten JJ; Morgan M
    Anaesthesia; 1997 Mar; 52(3):244-60. PubMed ID: 9124666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relation between serum cholinesterase and duration of the succinylcholine effect in the man. Preliminary note].
    Appiani L; Carelli S; Dvelaickis D; Laveneziana D
    Quad Sclavo Diagn; 1971 Mar; 7(1):333-5. PubMed ID: 5155192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum Cholinesterase and Succinylcholine].
    GROHMANN W
    Anaesthesist; 1957 Apr; 6(2):136-8. PubMed ID: 13444642
    [No Abstract]   [Full Text] [Related]  

  • 37. Atracurium: its speed of onset. A comparison with suxamethonium.
    Scott RP; Goat VA
    Br J Anaesth; 1982 Sep; 54(9):909-11. PubMed ID: 7115602
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged neuromuscular blockade after administration of physostigmine and succinylcholine.
    Manoguerra AS; Steiner RW
    Clin Toxicol; 1981 Jul; 18(7):803-5. PubMed ID: 6273059
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrine inhibition of serum cholinesterase and prolonged succinylcholine action.
    Benveniste D; Hemmingsen L; Juul P
    Acta Anaesthesiol Scand; 1967; 11(3):297-309. PubMed ID: 6056544
    [No Abstract]   [Full Text] [Related]  

  • 40. Modification of atracurium blockade by halothane and by suxamethonium. A review of clinical experience.
    Stirt JA; Katz RL; Murray AL; Schehl DL; Lee C
    Br J Anaesth; 1983; 55 Suppl 1():71S-75S. PubMed ID: 6688021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.